ACLI Responds to Misinformation about COVID-19 Vaccine
The American Council of Life Insurers (ACLI) senior vice president of Policy Development, Paul Graham, recently responded to the social media news which suggested COVID-19 vaccines could be a factor a life insurer considers in the claims-paying process.
Recently, information has been spread on social media about the COVID-19 vaccines and life insurance.
The American Council of Life Insurers (ACLI) senior vice president of Policy Development, Paul Graham, recently responded to the information saying it is false.
According to a release, a social media post shared the false information discussing how COVID-19 vaccines could be a factor a life insurer considers in the claims-paying process.
Graham said life insurers don't consider whether or not a policyholder has received a COVID vaccine when deciding whether to pay a claim.
"Life insurance policy contracts are very clear on how policies work, and what cause, if any, might lead to the denial of a benefit," he said. "A vaccine for COVID-19 is not one of them. Policyholders should rest assured that nothing has changed in the claims-paying process as a result of COVID-19 vaccinations."
For further questions or concerns, it's recommended policyholders reach out to their life insurers, agents or financial professionals for their COVID-related questions.
Unrealistic Portrayals of Cardiac Arrest in Contemporary Film | ACC 2025
March 31st 2025Cardiac arrests in contemporary film are largely inaccurate when it comes to survival rate and etiology, according to a poster presented today at the American College of Cardiology conference held March 29 to 31 in Chicago.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Winrevair Reduced Risk of Morbidity and Mortality by 76% in PAH | ACC 2025
March 31st 2025In the ZENITH trial, Winrevair was evaluated based on a composite endpoint of all-cause death, lung transplantation or disease-related hospitalization for patients with pulmonary arterial hypertension.
Read More
Clopidogrel Beat Aspirin in Preventing Heart Attacks After PCI | ACC 2025
March 31st 2025Clopidogrel monotherapy may be an alternative to aspirin for prevention of cardiac events in high-risk patients after percutaneous coronary intervention, according to a new study presented at ACC 2025.
Read More
